Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma

BACKGROUND: Despite the acknowledged sex-related differences in immune response and immune checkpoint inhibitor (ICI) efficacy, little is known about the sex disparities in melanoma of novel genomic determinants for ICI therapies. METHODS: Pretreatment genomic profiles and clinical characteristics o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Fuyan, Zhang, Wenjing, Yang, Yichen, Yang, Yitao, Zhao, Junyi, Xie, Mengqi, Sheng, Chao, Wang, Suzhen, Wang, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594267/
https://www.ncbi.nlm.nih.gov/pubmed/34795662
http://dx.doi.org/10.3389/fimmu.2021.721409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594267/
https://www.ncbi.nlm.nih.gov/pubmed/34795662
http://dx.doi.org/10.3389/fimmu.2021.721409

Ejemplares similares